Johnson & Johnson has paused the advanced clinical trial of its experimental COVID-19 vaccine after one of their 60,000 participants became ill.
Johnson & Johnson has paused the advanced clinical trial of its experimental COVID-19 vaccine after one of their 60,000 participants became ill.
(Part 1) Eli Lilly has placed its COVID-19 vaccine trials on hold due to safety protocols. And a vaccine used to fight..
The trial was paused after a volunteer suffered an unexplained illness.